Abstract
The efferent synaptic specialization of hair cells includes a near-membrane synaptic cistern, whose presence suggests a role for internal calcium stores in cholinergic inhibition. Calcium release channels from internal stores include ‘ryanodine receptors’, whose participation is usually demonstrated by sensitivity to the eponymous plant alkaloid, ryanodine. However, use of this and other store-active compounds on hair cells could be confounded by the unusual pharmacology of the α9α10-containing hair cell nicotinic cholinergic receptor (nAChR), which has been shown to be antagonized by a broad spectrum of compounds. Surprisingly, we found that ryanodine, rather than antagonizing, is a positive modulator of the α9α10 nAChR expressed in Xenopus oocytes, the first such compound to be found. The effect of ryanodine was to increase the apparent affinity and efficacy for acetylcholine (ACh). Correspondingly, ACh-evoked currents through the isolated cholinergic receptors of inner hair cells in excised mouse cochleas were approximately doubled by 200 μM ryanodine, a concentration that inhibits gating of the ryanodine receptor itself. This unusual positive modulation was not unique to the mammalian receptor. The response to ACh of chicken ‘short’ hair cells likewise was enhanced in the presence of 100 μM ryanodine. This facilitatory effect on current through the AChR could enhance brief (∼1 s) activation of associated calcium-dependent K+ (SK) channels in both chicken short hair cells and rat outer hair cells. This novel effect of ryanodine provides new opportunities for the design of compounds that potentiate α9α10-mediated responses and for potential inner ear therapeutics based on this interaction.
Keywords: ryanodine, nicotinic receptors, α9α10 receptors, ion channels, acetylcholine, efferent system
INTRODUCTION
Ryanodine is a plant alkaloid that affects calcium-release channels, ‘ryanodine receptors’ (RyR) present in internal calcium stores identified in a variety of cell systems (Coronado et al. 1994; Rousseau et al. 1987) including hair cells of the cochlea (Lioudyno et al. 2004). Although an agonist at low concentrations, ryanodine acts as an antagonist of the calcium-release channels at higher concentrations. In isolated organelles, ryanodine converts from agonist to antagonist at concentrations >10 μM (Rousseau et al. 1987), but in intact cells, in which barriers to diffusion may exist, it has been shown to function as an agonist at concentrations as high as 50 μM (Lilly and Gollan 1995).
Acetylcholine (ACh) is the principal neurotransmitter released by medial olivocochlear efferent axons (Eybalin 1993). Existing data suggest that an atypical nicotinic receptor (nAChR) composed of α9 and α10 subunits plays a central role at the synapse between efferent fibers and outer hair cells (Elgoyhen et al. 1994; 2001). These receptors pass an inward cation current followed within milliseconds by the activation of calcium-dependent potassium channels of the SK subtype (Blanchet et al. 1996; Evans 1996; Fuchs and Murrow 1992a; Glowatzki and Fuchs 2000; Nenov et al. 1996; Oliver et al. 2000). In addition, the postsynaptic hair cell is endowed with a synaptic cistern coextensive with the presynaptic efferent contacts (Saito 1983). The term “synaptoplasmic” cistern of the hair cell was coined to recognize an analogy to the sarcoplasmic reticulum of muscle (Lioudyno et al. 2004). It has recently been shown that calcium-activated potassium currents in rat outer hair cells evoked by ACh were altered by compounds that act on intracellular calcium stores, presumably the closely associated synaptoplasmic cistern. Calcium-induced calcium release by RyRs has been proposed as the most likely mechanism of store coupling in hair cells of the cochlea (Lioudyno et al. 2004). Thus, as in muscle, where tight coupling of voltage-gated calcium channels to ryanodine receptors in the sarcoplasmic reticulum mediates calcium-induced calcium release, nAChRs trigger a subsequent calcium-dependent process in hair cells. Although this general mechanism remains valid, the present study illustrates a surprising refinement resulting from the pharmacological promiscuity of the hair cell’s AChR.
The α9 and α10 subunits that constitute the hair cell’s AChR are distant members of the ‘nicotinic’ receptor family, and when expressed in Xenopus laevis oocytes, form a heteromeric receptor-channel complex that displays a pharmacological profile distinctly different from that of other cholinergic receptors, with sensitivity to glycinergic, gabaergic, serotonergic, as well as nicotinic and muscarinic antagonists (Elgoyhen et al. 1994, 2001). Moreover, nicotine and most nicotinic agonists, except for ACh, behave as antagonists, or very weak partial agonists, of this receptor subtype. Given that the α9α10-containing hair cell cholinergic receptor is sensitive to a wide variety of chemically different compounds and that store coupling through calcium-induced calcium-release in hair cells has been proposed on the basis of pharmacological approaches (Lioudyno et al. 2004), we examined the direct action of ryanodine on α9α10-containing nAChRs. We report that ryanodine, in addition to acting on cytoplasmic calcium stores, is a positive modulator of the hair cell nAChR, the first such compound to be found. This opens the possibility for the design of related compounds that potentiate nAChR gating in cochlear hair cells (without also altering calcium store function) and therefore to increase potential benefits of medial efferent synaptic inhibition.
MATERIALS AND METHODS
Expression of recombinant receptors in X. laevis oocytes
Capped cRNAs were in vitro-transcribed from linearized rat plasmid DNA templates using the mMessage mMachine Transcription Kit (Ambion Corporation, Austin, TX). The maintenance of X. laevis, as well as the preparation and cRNA injection of stage V and VI oocytes, has been described in detail elsewhere (Katz et al. 2000). Typically, oocytes were injected with 50 nl of RNase-free water containing 0.01–1.0 ng of cRNAs (at a 1:1 molar, and maintained in Barth’s solution at 17°C.
Electrophysiological recordings were performed 2–6 days after cRNA injection under two-electrode voltage-clamp with an OC-725B oocyte clamp (Warner Instruments, Hamden, CT). Both voltage and current electrodes were filled with 3 M KCl and had resistances of ∼1–2 MΩ. Data were digitized and stored on a PC computer. Data were analyzed using Clampfit from the pClamp 6 software (Axon Instruments Corp., Union City, CA). During electrophysiological recordings, oocytes were continuously superfused (∼10 ml/min) with normal frog saline (comprised of, in mM: 115 NaCl, 2.5 KCl, 1.8 CaCl2, and 10 HEPES buffer, pH 7.2) and voltage-clamped at −70 mV. Experiments were performed in oocytes incubated with the Ca2+ chelator 1,2-bis (2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid-acetoxymethyl ester (BAPTA-AM, 100 μM) for 3–4 h before electrophysiological recordings. Drugs were applied in the perfusion solution of the oocyte chamber.
Concentration-response curves were normalized to the maximal agonist response in the absence of ryanodine. Ryanodine was added to the perfusion solution for 2 min before the addition of ACh and then were coapplied with this agonist. Responses were referred to as a percentage of the response to ACh. The mean and standard error of the mean of peak current responses are represented. Agonist concentration-response curves were iteratively fitted with the equation:
where I is the peak inward current evoked by the agonist at concentration A; Imax is current evoked by the concentration of agonist eliciting a maximal response; EC50 is the concentration of agonist inducing half-maximal current response, and n is the Hill coefficient.
Recordings from mouse inner hair cells
Apical turns of the organ of Corti were excised from CF1 mice at postnatal ages 8–10. Cochlear preparations were mounted under an Axioskope microscope (Zeiss, Oberkochen, Germany) and viewed with differential interference contrast (DIC) using a 40× water immersion objective and a camera with contrast enhancement (Hamamatsu C2400-07, Hamamatsu City, Japan). Methods to record from inner hair cells (IHCs) were essentially as described (Gomez-Casati et al. 2005). Briefly, IHC were identified visually by the size of their capacitance (7–12 pF) and by their characteristic voltage-dependent Na+ and K+ currents, including at older ages, a fast-activating K+-conductance. Some cells were removed to access IHCs, but mostly the pipette moved through the tissue using positive fluid flow to clear the tip. The extracellular solution was as follows (in mM): 155 NaCl, 5.8 KCl, 1.3 CaCl2, 0.9 MgCl2, 0.7 NaH2PO4, 5.6 d-glucose, and 10 HEPES buffer; pH 7.4. The pipette solution was (in mM): 150 KCl, 3.5 MgCl2, 0.1 CaCl2, 10 BAPTA, 5 HEPES buffer, 2.5 Na2ATP, pH 7.2. Glass pipettes (1.2 mm i.d.) had resistances of 7–10 MΩ. Solutions containing 60 μM ACh (the EC50 in this preparation) and ryanodine were applied by a gravity-fed multichannel glass pipette (∼150 μm tip diameter) positioned about 300 μm from the recorded IHC. The extracellular solution containing the drugs was similar to that described above, except that Mg2+ was omitted, and the Ca2+ concentration was lowered to 0.5 mM to optimize the experimental conditions for measuring currents flowing through the α9α10 receptors (Katz et al. 2004). To minimize even more the contribution of SK channel currents, in addition to using BAPTA in the pipette solution, the SK channel blocker apamin (1–10 nM) was added to the external working solutions. Currents in IHCs were recorded in the whole-cell patch-clamp mode using an Axopatch 200B amplifier, low-pass filtered at 2–10 kHz, and digitized at 5–20 kHz with a Digidata 1200 board (Axon Instruments, Union City, CA). Recordings were made at room temperature (22–25°C). Voltages were not corrected for the voltage drop across the uncompensated series resistance.
Whole-cell, gigohm-seal recording from isolated chicken hair cells
Short (outer) hair cells were isolated by microdissection from the chicken cochlea (2–10 days posthatch) after cervical dislocation and decapitation. The cochlear duct was removed from the inner ear and treated with 0.1 mg ml−1 protease (Sigma Type XXIV) in low-divalent saline for 3–10 min at room temperature. The tegmentum vasculosum was cut away, exposing the basilar papilla. The tectorial membrane was pealed away with fine forceps, and a sharpened tungsten probe was used to cut several slits through the basilar papilla to loosen hair cells for eventual removal. A glass capillary (tip diameter about 50 μm) was used with mouth suction to vacuum hair cells from selected regions of the papilla. These were carefully plated onto a clean glass coverslip that served as the floor of the recording chamber. Short hair cells were collected from the abneural half of the epithelium between 1 and 2 mm from the apical (lagenar) end of the papilla. Because only small numbers of hair cells were collected at any one time, repeated isolates could be taken from one cochlea. Between isolations, the cochlear duct was either stored in a 37°C, humidified incubator, or at room temperature under an ‘oxygen tent’ through which oxygen gas was passed continuously. Recordings were attempted from one set of isolated cells for 1–2 h, and the cochlea was returned to for more cells over a period of 3–4 h.
Isolated hair cells were placed in a recording chamber on the stage of a Nikon Diaphot inverted microscope. Patch pipettes of 3–5 MΩ were pulled from borosilicate hematocrit glass (#2-00-100, Drummond Scientific, Broomall, PA) and coated with purple ski-wax to reduce capacitance. Seals of 2–20 GΩ were made to the cell surface, then the whole-cell configuration was obtained by further brief pulses of suction. ACh (100 μM) was applied from a ‘puffer’ pipette—another patch pipette filled with 100 μM ACh in external saline, mounted on manipulator, and connected to a Picospritzer (General Valve Corp., Fairfield, NJ) for controlled pressure ejection. In most cases, a 100-ms puff of ACh was employed. Membrane currents were recorded under a voltage clamp (Axopatch 1D, Axon Instruments, Union City, CA), filtered at 5 or 10 kHz, and digitized at 100-μs intervals. Membrane potentials are reported here without correction for the junction potential of −4 mV. Bath solutions were exchanged by gravity feed and suction drain. The standard external saline contained (mM): NaCl, 150; KCl, 5; MgCl2, 2; CaCl2, 5.6; HEPES, 5; glucose, 8, adjusted to pH 7.4 with NaOH. The osmolarity was adjusted to 315 mOsm with the predominant salt. The recording pipette contained (mM): 112 KCl, 2 MgCl2, 0.1 CaCl2, 30 KOH, 10 EGTA, 10 HEPES and 5 Na2ATP (titrated to pH 7.2 with KOH; osmolarity adjusted to 295 mOsm). In some recordings, BAPTA was exchanged for EGTA. Ryanodine and other drugs were diluted from stock solutions and perfused through the recording chamber. Total bath volume was less than 0.5 ml and replacement occurred within 15 s. However, several bath volumes of a new solution were exchanged before recordings were made. All experiments were conducted at room temperature (22–24°C).
Whole-cell, gigohm-seal recording from isolated outer hair cells
The apical and upper middle turns were dissected from the otic capsule of 12- to 17-day-old rat pups. The excised turns were treated briefly with protease (5 min in 0.1 mg/ml of papain at room temperature); then, the organ of Corti was dissociated by aspiration into a small diameter pipette. The individually isolated cells were dispersed onto the clean glass floor of a recording chamber secured to the stage of an inverted microscope (Nikon Diaphot). Whole-cell, gigohm-seal recording conditions and solutions were the same as those used for the chicken hair cell experiments described above.
Statistical analysis
The statistical significance of differences between mean values was assessed by Student’s t test (two-tailed, unpaired samples). Values of p < 0.05 were considered significant. Unless otherwise stated, data is expressed as the mean ± SEM.
Materials
ACh chloride or iodide was bought from Sigma-Aldrich Chemical Co. (St. Louis, MO). Ryanodine was obtained from various vendors including Sigma-Aldrich, LaToxan (Valence, France), and Tocris (Bristol, UK).
All experimental protocols were carried out in accordance with the Animal Care and Use Committee of Johns Hopkins University and with the National Institute of Health guide for the care and use of Laboratory animals (NIH Publications no. 80–23) revised 1978.
RESULTS
Ryanodine potentiates ACh-evoked responses in α9α10-expressing Xenopus oocytes
To analyze the effect of ryanodine on α9α10 receptors, we examined its action on agonist-evoked currents in Xenopus oocytes expressing the rat recombinant receptors. A concentration of 10 μM ACh was initially used as it is near the EC50 for the agonist in this preparation (Elgoyhen et al. 2001). Shown in Figure 1 are representative current traces at increasing concentrations of ryanodine coapplied with ACh compared to controls before and after ryanodine. Ryanodine at concentrations greater than 100 μM produced a significant potentiation of the response to ACh. In the presence of 100 μM ryanodine the response to ACh was 95–165% that of the control, with a mean of 122.76 ± 8.07% (n = 9); in 200 μM, 104–1,344%, mean 417.7 ± 192.9% (n = 8, p < 0.046) and 103–1279%, mean 503.37 ± 388.06 (n = 3) in 300 μM ryanodine (Fig. 2A). Preincubation with ryanodine gave similar results as did coapplication. In addition, ryanodine itself did not elicit membrane currents in the absence of ACh, arguing against a direct effect of ryanodine on oocytes’ intracellular Ca2+ stores and subsequent alteration in the activation of the Ca2+-dependent Cl− current present in these cells (Boton et al. 1989).
To further characterize the effects and mechanism of action of 200 μM ryanodine, we examined its action on ACh concentration-response curves. As seen in Figure 2B, ryanodine produced a left-ward shift of the dose–response curve, with a concomitant decrease in the EC50 for ACh from 15.4 ± 1.63 μM to 6.7 ± 3.08 μM (n = 3–7 for each data point; p < 0.05) but with no change in the Hill coefficient. Moreover, incubation with ryanodine resulted in an increase in the agonist-evoked currents, even at concentrations of agonist that evoked maximal responses in control conditions (136.4 ± 12.55% of the control response, n = 3–7 for each data point).
Ryanodine potentiates ACh-evoked responses in native α9α10-containing mouse hair cell receptors
The experiments in oocytes provide a clear demonstration that ryanodine potentiates responses of α9α10 receptors. This is the first of such compounds to be found and opens the possibility of designing new molecules that modulate synaptic responses mediated through α9α10 nAChRs in vivo. Mature outer and neonatal inner cochlear hair cells are the main targets of descending cholinergic olivocochlear efferent fibers (Guinan 1996). ACh released from efferent endings activates α9α10 nAChRs in hair cells (Elgoyhen et al. 1994, 2001; Gomez-Casati et al. 2005; Lustig et al. 2001; Sgard et al. 2002). Thus, recordings from inner hair cells of the neonatal mouse cochlea were used to evaluate the effects of ryanodine on native α9α10 nAChRs. As shown in Figure 3, 200 μM of ryanodine potentiated responses (264.4 ± 51% of the control, n = 8) to 60 μM ACh (the EC50 of the agonist in this preparation; Gomez-Casati et al. 2005), thus demonstrating a modulatory effect of ryanodine on native α9α10-containing receptors. These recordings were performed with cytoplasmic calcium buffered by BAPTA, plus 10 nM apamin in the external saline, to prevent activation of the associated SK current (Gomez-Casati et al. 2005), confirming that ryanodine was acting directly on the hair cell’s AChRs.
Effect of ryanodine on the cholinergic response of chicken hair cells
This effect of ryanodine was not unique to mammalian hair cells. Short hair cells are the avian counterpart of mammalian outer hair cells (OHCs). Like OHCs, short hair cells are contacted by efferent fibers that release ACh to elicit a biphasic membrane current (Fuchs and Murrow 1992b). Calcium influx through a ‘nicotinic’ AChR is followed by the activation of calcium-dependent SK channels (Fuchs and Murrow 1992b; McNiven et al. 1996). As in the foregoing experiments in the rat cochlea, current through the chicken short hair cell AChR alone can be studied when cytoplasmic calcium is buffered with BAPTA (10 mM). As shown in Figure 4, inward currents at −70 mV, elicited by brief (100 ms) application of 100 μM ACh, were potentiated by 100 μM ryanodine (peak inward currents in control averaged −10.1 pA, ± 1.6, n = 13; after exposure to ryanodine, −45.3 pA ± 6.3, n = 13, p < 0.01). In addition to the marked increase in peak current, the time to peak increased ∼threefold (from 20 ms ± 3.5 to 75 ms ± 25, p < 0.05). However, half-decay time was not changed significantly (control: 922 ms ± 183, vs ryanodine: 1,092 ms ± 150), Figure 4B. ACh receptors in chicken hair cells, like in mammals, are most sensitive to block by strychnine (Fuchs and Murrow 1992b). The ryanodine-potentiated inward currents were blocked completely and reversibly by 1 μM strychnine (Fig. 4C), further supporting the notion that the potentiating effect was specific to the hair cell AChR. Consistent with this point, the reversal potential for the ryanodine-enhanced inward current, +4 mV, was unchanged from that of the control inward current (McNiven et al. 1996). Finally, the potentiating effects of ryanodine were completely reversible.
The effect of ryanodine on the ACh-evoked SK current
The effect of ryanodine on the hair cell’s cholinergic response also could be studied under conditions (cytoplasmic calcium buffering with EGTA) that preserved the associated calcium-dependent SK current (Fuchs and Murrow 1992b). The outward SK current at −40 mV evoked by ACh was made longer-lasting, but not larger, by exposure to 100 μM ryanodine (Fig. 5A). The duration at half-amplitude nearly doubled (control duration at half amplitude: 435.4 ms ± 60.3, n = 18; in ryanodine: 772.3 ms ± 102.1, n = 18, p = 0.008); whereas peak amplitude was unchanged (control peak 425 pA ± 81, n = 18; ryanodine peak 383 pA ± 79, n = 18). This increase in SK current duration was readily reversed upon washing out ryanodine.
A similar result was obtained in a smaller number of OHCs dissociated from the apical turn of postnatal rats (P12-17). A 100-ms puff of 100 μM ACh produced outward currents at −40 to −50 mV membrane potential. These were smaller and longer-lasting, with irregular decay phases compared to those usually seen in isolated chicken hair cells (Fig. 5B). Nonetheless, exposure to 100 μM ryanodine lengthened the duration of the ACh response still further, nearly doubling the duration at half-amplitude (control 339 ms ± 54; ryanodine 516 ms ± 46, n = 4, p = 0.03). In addition, as in the chicken hair cells, the peak ACh-evoked current was not significantly changed by ryanodine (control, 44 pA ± 18; ryanodine, 53 pA ± 27). The effects of ryanodine on ACh-evoked SK currents in both chicken and rat hair cells support the conclusion that exposure to ryanodine enhances calcium influx through the hair cell’s AChR, as the activation of associated calcium-activated SK channels is prolonged. This is opposite to the expectation based on ryanodine’s inhibition of calcium release from internal stores. At least over the time scale of these responses then, the positive modulation of AChR gating outweighs any other effects ryanodine might have on calcium store function.
DISCUSSION
Cholinergic inhibition of the cochlea is mediated by an unusual member of the nicotinic receptor family of ligand-gated ion channels composed of α9 and α10 subunits (Elgoyhen et al. 1994, 2001). Not only do these nonselective cation channels paradoxically cause inhibition through associated calcium-dependent SK channels, but their pharmacology is unique, being antagonized rather than activated by nicotine and blocked by submicromolar concentrations of compounds such as strychnine and bicuculline (Elgoyhen et al. 2001; Rothlin et al. 1999). Indeed, with the exception of carbachol and acetylcholine itself, essentially none of the usual nicotinic agonists are effective, leaving the impression of a receptor subtype with broad antagonist sensitivity but one with a highly selective agonist binding site. Thus, in the absence of a wide variety of agonists, the identification of positive allosteric modulators of α9α10 receptors is an alternative way to reinforce endogenous cholinergic neurotransmission. The ability to modulate the function of hair cell AChRs offers a potentially powerful method for treating conditions such as hyperacusis or even as prophylaxis for unavoidable loud sound exposure. By altering the response of an ionotropic receptor to endogenous agonists, the modulator can change the level of signaling. One of the most successful examples of therapeutic intervention based on this strategy is the use of benzodiazepines to enhance the response of GABAA receptors and augment inhibitory activity in the central nervous system (Macdonald and Olsen 1994).
Like other ligand-gated ion channels, the α9α10 nAChR is both activated and desensitized by agonists in a concentration-dependent manner (Elgoyhen et al. 2001). Thus, continuous exposure to an agonist may impose a relatively narrow ‘effective-concentration’ range in which the receptors are activated but not fully desensitized (Hogg and Bertrand 2004). For example, in the case of α7 nAChRs, receptor desensitization may contribute to the relatively modest effect of nicotine on specific neurocognitive measures in human clinical studies (Harris et al. 2004; Smith et al. 2002). Unlike agonists, positive allosteric modulators do not directly activate or desensitize ligand-gated receptors; instead, they enhance the sensitivity and/or efficacy of the receptor during agonist activation. The positive modulatory effects of ryanodine reported here were especially surprising and are the first to be described for α9α10 nAChRs, encouraging further exploration of this molecular pharmacology. This interaction may provide general instruction toward a pharmacological design for allosteric modulators that are effective at the synapse between olivocochlear fibers and hair cells of the inner ear.
Ryanodine increased both the potency, as well as the maximal response of α9α10 nAChRs for ACh in Xenopus laevis oocytes. Moreover, potentiation was also observed in native α9α10-containing receptors. The fact that potentiation occurred within seconds and was reversible suggests that incorporation of receptors, whether newly synthesized or drawn from intracellular stores, seems an unlikely explanation. As has been proposed for the potentiating effect of certain compounds on other nAChRs (Conroy et al. 2003; Curtis et al. 2002; Hurst et al. 2005; Krause et al. 1998; Zwart et al. 2002), the most likely interpretation of the present results is that ryanodine acts as a positive allosteric effector, recognizing a specific binding site within the receptor protein. Another formal possibility is that ryanodine is having its effect through ‘conformational coupling’ between hair cell AChRs and ryanodine receptors (RyR) as occurs during calcium release from sarcoplasmic reticulum in skeletal muscle. The close (20–30 nm) apposition of plasma and cisternal membranes in hair cells approximates that at triadic junctions in muscle. Of course, for this explanation to hold, α9α10 also would have to interact with native RyRs in Xenopus oocytes, and these seem to be absent in these cells (Parys et al 1992). Whatever the eventual resolution of binding mechanism, it will be of interest to determine whether the effect of ryanodine includes an alteration of channel gating per se, as suggested by the increased maximal response and altered activation of hair cell responses to ACh.
Comparisons to earlier work
The results presented here are opposite in effect to the known inhibition by ryanodine of calcium release in muscle and other cell types (Buck et al. 1992; Sutko et al. 1997). More significantly, these are at odds with earlier work showing that ryanodine inhibits cholinergic action on outer hair cells of the rat cochlea (Lioudyno et al. 2004). In the present study, high concentrations of ryanodine (100 μM) prolonged the SK current generated in rat OHCs by a brief application of ACh (Fig. 5). The earlier study showed that 100 μM of ryanodine reduced the amplitude of ACh-evoked currents in rat OHCs in the ex vivo organ of Corti preparation and left the time course of synaptic waveforms unchanged. A partial reconciliation of the earlier results and the present data can be obtained by recognizing that ryanodine also can act to alter the contribution of internal stores to the ACh-evoked, calcium-dependent K+ currents. In the earlier work, a weaker cytoplasmic buffer (5 vs 10 mM EGTA) may have allowed ryanodine’s inhibition of better-loaded calcium stores to predominate (Lioudyno et al. 2004). Given the complexity of ryanodine’s effects, a given outcome will depend on experimental conditions. The enhanced activation of hair cell AChRs shown here may explain in part the enhancement of efferent inhibition produced by ryanodine in the guinea pig cochlea (Sridhar et al. 1997).
Consideration of these studies makes clear that intracellular calcium stores, especially near-membrane synaptic cisterns like those in hair cells, make challenging subjects for investigation. The contributions of such stores will depend on their state of loading, the efficacy of buffering and pumping, and the time course of stimulation. Furthermore, pharmacological agents aimed at store function can have multiphasic effects, depending on timing. For example, the ryanodine receptor agonist caffeine first enhanced and then suppressed ACh-evoked SK currents in rat OHCs (Lioudyno et al. 2004). These complexities are exacerbated by the relative nonselectivity of most such store-active compounds. The present study takes this one step further by showing that ryanodine, a quintessential tool for studying calcium stores, has still further sites of action. In summary, this work demonstrates a novel, positive modulation of the hair cell’s α9α10-containing AChR by the store-active agent ryanodine. These data provide new insights into the characteristics of this unusual nicotinic receptor and advance our understanding of the molecular mechanisms of cochlear inhibition.
Acknowledgments
This work was supported by an International Research Scholar Grant from the Howard Hughes Medical Institute and a Research Grant from ANPCyT (Argentina) to A.B.E., a Research grant from Universidad de Buenos Aires (Argentina) to A.B.E. and E.K., a Research Grant from CONICET (Argentina) to E.K., and the National Institutes of Deafness and other Communication Disorders (NIDCD) Grant R01DC001508 to P.A.F. and A.B.E.
References
- Blanchet C, Erostegui C, Sugasawa M, Dulon D. Acetylcholine-induced potassium current of guinea pig outer hair cells: its dependence on a calcium influx through nicotinic-like receptors. J. Neurosci. 16:2574–2584, 1996. [DOI] [PMC free article] [PubMed]
- Boton R, Dascal N, Gillo B, Lass Y. Two calcium-activated chloride conductances in Xenopus laevis oocytes permeabilized with the ionophore A23187. J. Physiol. 408:511–534, 1989. [DOI] [PMC free article] [PubMed]
- Buck E, Zimanyi I, Abramson JJ, Pessah IN. Ryanodine stabilizes multiple conformational states of the skeletal muscle calcium release channel. J. Biol. Chem. 267:23560–23567, 1992. [PubMed]
- Conroy WG, Liu QS, Nai Q, Margiotta JF, Berg DK. Potentiation of alpha7-containing nicotinic acetylcholine receptors by select albumins. Mol. Pharmacol. 63:419–428, 2003. [DOI] [PubMed]
- Coronado R, Morrissette J, Sukhareva M, Vaughan DM. Structure and function of ryanodine receptors. Am. J. Physiol. 266:C1485–C1504, 1994. [DOI] [PubMed]
- Curtis L, Buisson B, Bertrand S, Bertrand D. Potentiation of human alpha4beta2 neuronal nicotinic acetylcholine receptor by estradiol. Mol. Pharmacol. 61:127–135, 2002. [DOI] [PubMed]
- Elgoyhen AB, Johnson DS, Boulter J, Vetter DE, Heinemann S. α9: an acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells. Cell. 79:705–715, 1994. [DOI] [PubMed]
- Elgoyhen AB, Vetter D, Katz E, Rothlin C, Heinemann S, Boulter J. Alpha 10: A determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells. Proc. Nat. Acad. Sci. U. S. A. 98:3501–3506, 2001. [DOI] [PMC free article] [PubMed]
- Evans M. Acetylcholine activates two currents in guinea-pig outer hair cells. J. Physiol. 491:563–578, 1996. [DOI] [PMC free article] [PubMed]
- Eybalin M. Neurotransmitters and neuromodulators of the mammalian cochlea. Physiol. Rev. 73:309–373, 1993. [DOI] [PubMed]
- Fuchs PA, Murrow BW. Cholinergic inhibition of short (outer) hair cells of the chick’s cochlea. J. Neurosci. 12:800–809, 1992a. [DOI] [PMC free article] [PubMed]
- Fuchs PA, Murrow BW. A novel cholinergic receptor mediates inhibition of chick cochlear hair cells. Proc. R. Soc. Lond. B. 248:35–40, 1992b. [DOI] [PubMed]
- Glowatzki E, Fuchs P. Cholinergic synaptic inhibition of inner hair cells in the neonatal mammalian cochlea. Science. 288:2366–2368, 2000. [DOI] [PubMed]
- Gomez-Casati ME, Fuchs PA, Elgoyhen AB, Katz E. Biophysical and pharmacological characterization of nicotinic cholinergic receptors in cochlear inner hair cells. J. Physiol. 566:103–118, 2005. [DOI] [PMC free article] [PubMed]
- Guinan JJ. Physiology of olivocochlear efferents. In: Dallos P, Popper AN, and Fay RR (eds) The Cochlea. New York, Springer, pp 435–502, 1996.
- Harris JG, Kongs S, Allensworth D, Martin L, Tregellas J, Sullivan B, Zerbe G, Freedman R. Effects of nicotine on cognitive deficits in schizophrenia. Neuropsychopharmacol. 29:1378–1385, 2004. [DOI] [PubMed]
- Hogg RC, Bertrand D. Nicotinic acetylcholine receptors as drug targets. Curr. Drug. Targets CNS Neurol. Disord. 3:123–130, 2004. [DOI] [PubMed]
- Hurst RS, Hajos M, Raggenbass M, Wall TM, Higdon NR, Lawson JA, Rutherford-Root KL, Berkenpas MB, Hoffmann WE, Piotrowski DW, Groppi VE, Allaman G, Ogier R, Bertrand S, Bertrand D, Arneric SP. A novel positive allosteric modulator of the alpha7 neuronal nicotinic acetylcholine receptor: in vitro and in vivo characterization. J. Neurosci. 25:4396–4405, 2005. [DOI] [PMC free article] [PubMed]
- Katz E, Verbitsky M, Rothlin C, Vetter D, Heinemann S, Elgoyhen A. High calcium permeability and calcium block of the α9 nicotinic acetylcholine receptor. Hearing Res. 141:117–128, 2000. [DOI] [PubMed]
- Katz E, Elgoyhen AB, Gomez-Casati ME, Knipper M, Vetter DE, Fuchs PA, Glowatzki E. Developmental regulation of nicotinic synapses on cochlear inner hair cells. J. Neurosci. 24:7814–7820, 2004. [DOI] [PMC free article] [PubMed]
- Krause RM, Buisson B, Bertrand S, Corringer PJ, Galzi JL, Changeux JP, Bertrand D. Ivermectin: a positive allosteric effector of the alpha7 neuronal nicotinic acetylcholine receptor. Mol. Pharmacol. 53:283–294, 1998. [DOI] [PubMed]
- Lilly LB, Gollan JL. Ryanodine-induced calcium release from hepatic microsomes and permeabilized hepatocytes. Am. J. Physiol. 268:G1017–G1024, 1995. [DOI] [PubMed]
- Lioudyno M, Hiel H, Kong JH, Katz E, Waldman E, Parameshwaran-Iyer S, Glowatzki E, Fuchs PA. A “synaptoplasmic cistern” mediates rapid inhibition of cochlear hair cells. J. Neurosci. 24:11160–11164, 2004. [DOI] [PMC free article] [PubMed]
- Lustig LR, Peng H, Hiel H, Yamamoto T, Fuchs P. Molecular cloning and mapping of the human nicotinic acetylcholine receptor a10 (CHRNA10). Genomics. 73:272–283, 2001. [DOI] [PubMed]
- Macdonald RL, Olsen RW. GABAA receptor channels. Annu. Rev. Neurosci. 17:569–602, 1994. [DOI] [PubMed]
- McNiven AI, Yuhas WA, Fuchs PA. Ionic dependence and agonist preference of an acetylcholine receptor in hair cells. Auditory Neurosci. 2:63–77, 1996.
- Nenov AP, Norris C, Bobbin RP. Acetylcholine responses in guinea pig outer hair cells. II Activation of a small conductance Ca2+-activated K+ channel. Hearing Res. 101:149–172, 1996. [DOI] [PubMed]
- Oliver D, Klocker N, Schuck J, Baukrowitz T, Ruppersberg JP, Fakler B. Gating of Ca2+-activated K+ channels controls fast inhibitory synaptic transmission at auditory outer hair cells. Neuron. 26:595–601, 2000. [DOI] [PubMed]
- Parys JB, Sernett SW, DeLisle S, Snyder PM, Welsh MJ, Campbell KP. Isolation, characterization, and localization of the inositol 1,4,5-trisphosphate receptor protein in Xenopus laevis oocytes. J. Biol. Chem. 267:18776–18782, 1992. [PubMed]
- Rothlin C, Verbitsky M, Katz E, Elgoyhen A. The α9 nicotinic acetylcholine receptor shares pharmacological properties with type A g-aminobutyric acid, glycine and type 3 serotonin receptors. Molec. Pharmacol. 55:248–254, 1999. [DOI] [PubMed]
- Rousseau E, Smith JS, Meissner G. Ryanodine modifies conductance and gating behavior of single Ca2+ release channel. Am. J. Physiol. 253:C364–C368, 1987. [DOI] [PubMed]
- Saito K. Fine structure of the sensory epithelium of guinea-pig organ of Corti: subsurface cisternae and lamellar bodies in the outer hair cells. Cell Tissue Res. 229:467–481, 1983. [DOI] [PubMed]
- Sgard F, Charpentier E, Bertrand S, Walker N, Caput D, Graham D, Bertrand D, Besnard F. A novel human nicotinic receptor subunit, α10, that confers functionality to the α9-subunit. Molec. Pharmacol. 61:150–159, 2002. [DOI] [PubMed]
- Smith RC, Singh A, Infante M, Khandat A, Kloos A. Effects of cigarette smoking and nicotine nasal spray on psychiatric symptoms and cognition in schizophrenia. Neuropsychopharmacol. 27:479–497, 2002. [DOI] [PubMed]
- Sridhar TS, Brown MC, Sewell WF. Unique postsynaptic signaling at the hair cell efferent synapse permits calcium to evoke changes on two time scales. J. Neurosci. 17:428–437, 1997. [DOI] [PMC free article] [PubMed]
- Sutko JL, Airey JA, Welch W, Ruest L. The pharmacology of ryanodine and related compounds. Pharmacol. Rev. 49:53–98, 1997. [PubMed]
- Zwart R, De Filippi G, Broad LM, McPhie GI, Pearson KH, Baldwinson T, Sher E. 5-Hydroxyindole potentiates human alpha 7 nicotinic receptor-mediated responses and enhances acetylcholine-induced glutamate release in cerebellar slices. Neuropharmacol. 43:374–384, 2002. [DOI] [PubMed]